金妇康品牌怎么样申请店铺

我要投票

金妇康在乌鸡白凤丸行业中的票数：647 更新时间：2026-02-01

金妇康是哪个国家的品牌？「金妇康」是中华茂祥集团有限公司旗下著名品牌。该品牌发源于吉林省通化市，由创始人王瀚基在1996-02-08期间创立，经过多年的不懈努力和高速发展，现已成为行业的标杆品牌。

外推网助力金妇康品牌出海！将品牌入驻外推网，定制金妇康品牌推广信息，可以显著提高金妇康产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

创建于1984年，乌鸡白凤丸行业知名品牌，以医药为主，兼营房产/葡萄酒等生产的多元化集团企业

中华茂祥集团有限公司创业于1984年，经过二十年的不懈努力，公司已发展为医药为主，同时兼营房产、葡萄酒等生产，总资产12.5亿元的多元化的集团企业。占地面积65万平方米，总建筑面积5.5万平方米，员工近5000人，市场网络遍布全国。集团下设通化茂祥制药有限公司、通化茂祥药业股份有限公司、茂祥集团（长春）制药有限公司、茂祥集团（吉林）制药有限公司、吉林省祥和房地产开发有限公司、通化茂祥葡萄酒股份有限公司、通化市新华彩印厂等多家子公司。

多年来，中华茂祥集团有限公司本着开拓进取、求实创新的宗旨，为对社会、对人民高度负责的态度，自主经营、自我发展，注重产品开发，信守“营造健康、维护健康和为生命创造奇迹”的理念，坚持科技创新，科技投入达到年销售收入的15%以上，加速成果转化和新药品的产业化，立足医药，不断增强医药产业核心竞争力，使茂祥集团的经济发展呈现出良性循环的可喜势头。集团现有按国家GMP标准设计的注射用抗生素粉针剂和固体制剂、液体制剂等多条制药生产线，可生产化学合成原料药和胶囊剂（含缓释剂、控释制剂）、片剂（含缓释剂、控释剂）、颗粒剂、粉针剂、水针剂、软胶囊、滴丸、口服液、糖浆剂、软膏、栓剂、蜜丸13种剂型289个品种。公司生产系列中西药产品泰克、金妇康、安神胶囊、先泰、普舒等以良好的疗效赢得广大患者的认可，成为国内出色品牌。

Founded in 1984, Zhonghua Maoxiang Group Co., Ltd., a well-known brand in Wuji Baifeng pill industry, was founded in 1984. After 20 years of unremitting efforts, the company has developed into a diversified group enterprise with a total assets of 1.25 billion yuan, mainly engaged in the production of real estate and wine. Covering an area of 650000 square meters, with a total construction area of 55000 square meters and nearly 5000 employees, the market network covers the whole country. The group consists of Tonghua Maoxiang Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Maoxiang group (Changchun) Pharmaceutical Co., Ltd., Maoxiang group (Jilin) Pharmaceutical Co., Ltd., Jilin Xianghe Real Estate Development Co., Ltd., Tonghua Maoxiang Wine Co., Ltd., Tonghua Xinhua color printing factory and other subsidiaries. Over the years, China Maoxiang Group Co., Ltd. adheres to the tenet of pioneering, realistic and innovative, pays attention to product development, adheres to the philosophy of "creating health, maintaining health and creating miracles for life", adheres to scientific and technological innovation, achieves more than 15% of annual sales revenue in scientific and technological investment, and accelerates the transformation of achievements And the industrialization of new drugs, based on medicine, constantly enhance the core competitiveness of the pharmaceutical industry, so that the economic development of Maoxiang group presents a positive cycle of gratifying momentum. At present, the group has many pharmaceutical production lines designed according to the national GMP standards, such as antibiotic powder for injection, solid preparation and liquid preparation, which can produce chemical synthetic APIs and capsules (including sustained-release and controlled-release preparations), tablets (including sustained-release and controlled-release agents), granules, powder injection, water injection, soft capsule, drop pill, oral liquid, syrup, ointment, suppository and honeypill 13 289 kinds of dosage forms. The company produces a series of Chinese and Western medicine products, such as Taike, Jinfukang, Anshen capsule, Xiantai, proshu, etc., which win the recognition of the majority of patients with good curative effect and become an excellent brand in China.

本文链接： https://brand.waitui.com/7da436a8d.html 联系电话：请联系客服添加联系邮箱：请联系客服添加